Efficacy of human papillomavirus 16/18 ASO4-adjuvanted vaccine in Japanese women aged 20 to 25 years : interim analysis of a phase 2 double-blind, randomized, controlled trial.
Efficacy of human papillomavirus 16/18 ASO4-adjuvanted vaccine in Japanese women aged 20 to 25 years : interim analysis of a phase 2 double-blind, randomized, controlled trial.
复制标题
人乳头瘤病毒 16/18 ASO4 佐剂疫苗对 20 至 25 岁日本女性的功效：2 期双盲、随机、对照试验的中期分析。
作者：
Konno R;Yoshikawa H;et al.
